DCM Origination Strategy for Investment Bank

What are the usual DCM origination strategies deployed by banks that don't have a balance sheet (i.e. do not provide corporate loans)?

I understand that the DCM businesses in the FIG / SSA space are quite commoditized. Successful DCM origination teams often provide additional value-add (e.g. engaging clients' senior management in strategic discussions), on top of the usual intel (e.g. market and price updates) provided by all the other banks. 

However, corporate issuers usually give the DCM mandates to banks that already have existing relationships (more often than not, lending relationships) with them. In this case, how would a bank without balance sheet/security firms actually compete in the space? 

Some of the examples might have been oversimplified but would love to hear your thoughts on this.

 

Even if firms without a balance sheet (e.g. pure advisory banks) try to leverage the M&A angle, I imagine it would still be quite challenging given that the client would usually ask for a bridge-to-bond kind of arrangement. I always wonder how would firms like Morgan Stanley (might be a bad example as I don't know its business well enough), advisory-focused banks, compete in the DCM market? 

If said banks have a strong sales force and/or trading desks, perhaps they could try to bring potential issuers more private placement opportunities and/or liability management ideas (e.g. OMR/tender)?

 

I imagine that (i.e. all about lending) would be quite true for the corporate space. The SSA/FIG DCM space is probably leaning more towards closer/better coverage (e.g. market and pricing updates, constant flow of funding ideas AT1/T2) and occasional reciprocal transactions (e.g. engaging the potential FIG issuer for the bank's issuance).

What if you're the Head of DCM in a bank that has no lending capability? What would you do to build the business? 

 
Most Helpful

Sit ut porro officiis quod enim dolor. Eveniet qui ipsam quis eos vitae natus optio. Rerum odio nihil maiores et blanditiis eos voluptas. Necessitatibus blanditiis molestias aut. Dolorem et cupiditate recusandae unde sed aperiam. Odit magni perferendis pariatur id iste eaque nam odio.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
kanon's picture
kanon
98.9
8
dosk17's picture
dosk17
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”